Learn More
Eurofins Discoverx Troglitazone, 5 mg. (92-1138)
Supplier: Eurofins Discoverx 921138
Troglitazone is a selective agonist of the peroxisome proliferator-activated receptor-γ (PPARγ, EC50=555 nM) with no activity for PPARα or PPARδ. Troglitazone is a synthetic antidiabetic and anti-inflammatory drug previously prescribed to patients with type 2 diabetes mellitus, but was withdrawn from the market in 2000 due to toxicity issues. Provided as 5 mg of dry powder. These highly purified, pre-validated control ligands have been used to qualify our InCELL Hunter, PathHunter and cAMP Hunter cell lines as well as our Assay Ready Kits. Ligands are conveniently supplied with a recommended reconstitution buffer. For detailed information and product-specific datasheet, visit www.discoverx.com/ligands.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.